Page 6 - Atxs News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Atxs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Atxs Today - Breaking & Trending Today
Evercore ISI initiated coverage on shares of Astria Therapeutics (NASDAQ:ATXS – Get Rating) in a research note released on Tuesday, The Fly reports. The brokerage issued an outperform rating and a $18.00 target price on the biotechnology company’s stock. ATXS has been the subject of several other research reports. HC Wainwright restated a buy rating […] ....
Equities analysts predict that Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Rating) will announce earnings per share of ($0.73) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Astria Therapeutics’ earnings, with the highest EPS estimate coming in at ($0.61) and the lowest estimate coming in at ($0.83). Astria Therapeutics […] ....
Equities analysts predict that Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Rating) will post earnings per share (EPS) of ($0.69) for the current quarter, according to Zacks. Zero analysts have issued estimates for Astria Therapeutics’ earnings, with the lowest EPS estimate coming in at ($0.75) and the highest estimate coming in at ($0.61). Astria Therapeutics posted […] ....
Catabasis Pharmaceuticals (NASDAQ:ATXS – Get Rating)‘s stock had its “buy” rating reiterated by HC Wainwright in a research report issued to clients and investors on Friday, TipRanks reports. They presently have a $13.00 price objective on the biotechnology company’s stock. HC Wainwright’s price target suggests a potential upside of 83.10% from the stock’s current price. […] ....